- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.18 Å
- Oligo State
- hetero-2-1-1-1-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x CLR: CHOLESTEROL(Non-covalent)
CLR.6: 5 residues within 4Å:- Chain A: I.291, V.294, F.316, W.399, I.406
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.291, A:F.316, A:I.406, A:I.406
CLR.12: 8 residues within 4Å:- Chain C: L.297, V.300, L.304, R.307, I.318, F.439
- Chain D: Y.234, T.328
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.297, C:L.304, C:F.439, C:F.439
- Hydrogen bonds: C:R.307, C:R.307
CLR.14: 9 residues within 4Å:- Chain D: V.294, T.298, R.301, V.312, F.316, W.399, I.406, L.410
- Ligands: POV.15
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:V.294, D:V.312, D:F.316, D:W.399, D:I.406, D:L.410
- 4 x TC9: D-TUBOCURARINE(Non-covalent)
TC9.7: 15 residues within 4Å:- Chain A: Y.93, W.149, T.150, D.152, Y.190, C.192, Y.198
- Chain B: S.36, T.38, W.57, D.59, R.81, L.111, L.121, I.178
8 PLIP interactions:4 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:L.121, A:Y.198, A:Y.198
- Hydrogen bonds: B:S.36, B:R.81
- pi-Stacking: B:W.57, A:Y.190
- pi-Cation interactions: A:W.149
TC9.8: 6 residues within 4Å:- Chain A: V.259
- Chain B: Q.276
- Chain C: L.265, D.268
- Chain E: F.267, Q.271
4 PLIP interactions:1 interactions with chain C, 1 interactions with chain D, 1 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: C:D.268, A:V.259
- Salt bridges: D:E.262
- Hydrogen bonds: B:Q.276
TC9.13: 12 residues within 4Å:- Chain D: L.223, S.226, F.227, Y.277, F.280, T.281, F.284, F.414, I.417, C.418, G.421, S.424
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:Y.277, D:F.280, D:F.414, D:I.417
- Hydrogen bonds: D:S.424, D:S.424
TC9.16: 15 residues within 4Å:- Chain D: Y.93, W.149, T.150, Y.190, C.192, C.193, Y.198
- Chain E: K.34, W.55, R.79, L.109, Y.111, Y.117, L.119, E.163
11 PLIP interactions:5 interactions with chain D, 6 interactions with chain E- Hydrophobic interactions: D:W.149, D:Y.198, E:W.55, E:L.109, E:L.119
- Hydrogen bonds: D:T.150, D:Y.190, E:K.34, E:R.79
- pi-Stacking: D:W.149
- pi-Cation interactions: E:Y.117
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.9: 6 residues within 4Å:- Chain B: L.283, V.285, F.294, S.297
- Chain C: I.226, L.230
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:F.294, C:I.226, C:L.230
- Salt bridges: B:K.290
POV.10: 5 residues within 4Å:- Chain B: R.315
- Chain C: L.237, Y.240, R.437, Y.441
5 PLIP interactions:1 interactions with chain B, 4 interactions with chain C- Salt bridges: B:R.315, C:R.437
- Hydrophobic interactions: C:L.237, C:Y.240
- Hydrogen bonds: C:Y.240
POV.11: 8 residues within 4Å:- Chain C: V.277, R.282, M.285, F.286, I.289, I.449, G.450, I.454
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:F.286, C:I.289, C:I.449, C:I.454
POV.15: 11 residues within 4Å:- Chain D: V.294, N.297, R.301, H.306
- Chain E: S.235, V.238, L.239, F.242, K.449, L.456
- Ligands: CLR.14
8 PLIP interactions:3 interactions with chain D, 5 interactions with chain E- Hydrophobic interactions: D:V.294, E:V.238, E:L.239, E:F.242, E:L.456
- Hydrogen bonds: D:H.306
- Salt bridges: D:R.301, E:K.449
POV.17: 13 residues within 4Å:- Chain A: Y.234, T.328
- Chain E: Y.241, L.296, N.300, I.303, R.310, K.320, I.321, L.324, I.447, C.451, A.455
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:L.296, E:N.300, E:I.303, E:I.447, E:A.455
- Salt bridges: E:R.310
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rahman, M.M. et al., Structural mechanism of muscle nicotinic receptor desensitization and block by curare. Nat.Struct.Mol.Biol. (2022)
- Release Date
- 2022-03-09
- Peptides
- Acetylcholine receptor subunit alpha: AD
Acetylcholine receptor subunit delta: B
Acetylcholine receptor subunit beta: C
Acetylcholine receptor subunit gamma: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
DB
BC
CE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.18 Å
- Oligo State
- hetero-2-1-1-1-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x CLR: CHOLESTEROL(Non-covalent)
- 4 x TC9: D-TUBOCURARINE(Non-covalent)
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rahman, M.M. et al., Structural mechanism of muscle nicotinic receptor desensitization and block by curare. Nat.Struct.Mol.Biol. (2022)
- Release Date
- 2022-03-09
- Peptides
- Acetylcholine receptor subunit alpha: AD
Acetylcholine receptor subunit delta: B
Acetylcholine receptor subunit beta: C
Acetylcholine receptor subunit gamma: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
DB
BC
CE
E - Membrane
-
We predict this structure to be a membrane protein.